RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Chemical and Drug Induced Liver Injury
Accession: DOID:9007383
browse the term
Definition: A spectrum of clinical liver diseases ranging from mild biochemical abnormalities to ACUTE LIVER FAILURE, caused by drugs, drug metabolites, herbal and dietary supplements and chemicals from the environment.
Synonyms: exact_synonym: Chemically Induced Liver Toxicity; Drug Induced Acute Liver Injury; Drug Induced Liver Disease; Drug Induced Liver Injury; Drug-Induced Liver Diseases; Drug-Induced Liver Injuries; Toxic Hepatitis; chemically-induced liver toxicities; hepatotoxicity; toxic hepatitides
narrow_synonym: Drug-induced liver injury due to flucloxacillin
primary_id: MESH:D056486
alt_id: RDO:0007742
xref: EFO:0004228 ; EFO:0011052 ; NCI:C84427
GViewer not supported for the selected species.
G
AASS
aminoadipate-semialdehyde synthase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr21:90,891,781...90,959,351
Ensembl chr21:90,892,023...90,959,343
G
ABCB1
ATP binding cassette subfamily B member 1
severity susceptibility
ISO
DNA:SNP::2677G>T/A(rs2032582)(human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:20623750 PMID:26134275 PMID:27296832
RGD:11041130 RGD:14700895
NCBI chr21:61,211,044...61,430,691
Ensembl chr21:61,322,748...61,529,274
G
ABCB11
ATP binding cassette subfamily B member 11
severity
ISO
DNA:SNP: :rs2287616(human)
RGD
PMID:27293027
RGD:14402413
NCBI chr10:54,458,283...54,575,943
Ensembl chr10:54,459,377...54,575,059
G
ABCC1
ATP binding cassette subfamily C member 1 (ABCC1 blood group)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18466103
NCBI chr 5:14,972,589...15,164,594
Ensembl chr 5:14,972,646...15,164,567
G
ABCC2
ATP binding cassette subfamily C member 2
susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:polymorphism:promoter:-24C>T(human)
CTD RGD
PMID:17241877 PMID:18381794 PMID:18466103 PMID:25196354
RGD:14700812 RGD:14700814
NCBI chr 9:92,826,423...92,902,389
Ensembl chr 9:92,841,818...92,902,265
G
ABI1
abl interactor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 9:26,377,822...26,495,665
Ensembl chr 9:26,379,516...26,495,676
G
ACOX3
acyl-CoA oxidase 3, pristanoyl
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr27:44,313,297...44,366,702
G
ACSL1
acyl-CoA synthetase long chain family member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 7:130,712,633...130,783,360
Ensembl chr 7:130,712,308...130,763,756
G
ACTB
actin beta
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:liver
CTD RGD
PMID:22563491 PMID:25231249
RGD:9587759
NCBI chr28:16,195,676...16,197,161
Ensembl chr12:52,426,752...52,427,879
G
ACTN4
actinin alpha 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 6:33,290,639...33,373,059
Ensembl chr 6:33,290,622...33,374,693
G
ACTR3
actin related protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr10:16,296,350...16,369,561
Ensembl chr10:16,297,502...16,369,220
G
ADA
adenosine deaminase
ISO
protein:increased expression:liver
RGD
PMID:21161045
RGD:5128859
NCBI chr 2:19,167,209...19,200,233
G
ADAM8
ADAM metallopeptidase domain 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24646716
NCBI chr26:53,114,184...53,129,650
Ensembl chr26:53,114,924...53,126,900
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20709802
NCBI chr15:81,128,427...81,142,779
Ensembl chr15:81,129,795...81,147,391
G
ADIPOR2
adiponectin receptor 2
severity
ISO
associated with obesity, LPS;mRNA:decreased expression:liver (rat)
RGD
PMID:23838384
RGD:8695926
NCBI chr11:1,802,694...1,836,703
Ensembl chr11:1,738,026...1,837,060
G
ADORA2B
adenosine A2b receptor
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:35292334
NCBI chr16:15,682,669...15,712,079
Ensembl chr16:15,683,077...15,711,858
G
AGT
angiotensinogen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29499335
NCBI chr25:67,964,840...67,977,006
Ensembl chr25:67,962,401...67,973,324
G
AHR
aryl hydrocarbon receptor
ISO
CTD Direct Evidence: marker/mechanism|therapeutic mRNA:decreased expression:liver (rat)
CTD RGD
PMID:21890736 PMID:28959666 PMID:34848246
RGD:401794432
NCBI chr21:40,778,198...40,826,491
Ensembl chr21:40,778,218...40,826,478
G
AIFM1
apoptosis inducing factor mitochondria associated 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25743375
NCBI chr X:105,383,408...105,419,146
Ensembl chr X:105,382,693...105,419,095
G
AK4
adenylate kinase 4
ISO
protein:increased expression:liver (rat)
RGD
PMID:16538043
RGD:2301096
NCBI chr20:67,840,572...67,924,691
G
AKR1A1
aldo-keto reductase family 1 member A1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:29763686 PMID:32805337
RGD:27226688
NCBI chr20:87,228,348...87,245,511
Ensembl chr20:87,228,189...87,245,466
G
ALB
albumin
treatment
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:18779383 PMID:22310181 PMID:27567545
RGD:14694844
NCBI chr 7:21,872,036...21,890,095
Ensembl chr 7:21,876,132...21,891,407
G
ALDH1L2
aldehyde dehydrogenase 1 family member L2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr11:100,242,649...100,311,164
Ensembl chr11:100,247,262...100,298,621
G
ALDH2
aldehyde dehydrogenase 2 family member
severity susceptibility
ISO
DNA:deletion:exon 3 (mouse) protein:increased expression:liver
RGD
PMID:21138988 PMID:24492981 PMID:30121625
RGD:14975148 RGD:15036810 RGD:7241599
NCBI chr11:107,019,015...107,060,784
Ensembl chr11:107,019,111...107,060,374
G
ALDH9A1
aldehyde dehydrogenase 9 family member A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr25:63,184,220...63,223,865
G
ALDOB
aldolase, fructose-bisphosphate B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16115720
NCBI chr12:37,993,367...38,021,693
Ensembl chr12:38,007,265...38,021,258
G
AMBP
alpha-1-microglobulin/bikunin precursor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18779383
NCBI chr12:25,508,516...25,526,821
Ensembl chr12:25,508,682...25,527,016
G
ANXA2
annexin A2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr26:23,100,000...23,147,687
Ensembl chr26:23,099,992...23,145,457
G
ANXA6
annexin A6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr23:53,657,377...53,714,828
Ensembl chr23:53,657,718...53,714,850
G
APOA1
apolipoprotein A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr 1:108,201,967...108,203,902
Ensembl chr 1:108,201,439...108,203,609
G
APOE
apolipoprotein E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr 6:38,377,154...38,381,219
Ensembl chr 6:38,376,887...38,381,438
G
APOH
apolipoprotein H
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:plasma:
CTD RGD
PMID:16099942 PMID:23288050
RGD:10054107
NCBI chr16:55,209,142...55,231,176
G
ARG1
arginase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22872058
NCBI chr13:41,971,955...41,983,372
Ensembl chr13:41,971,802...41,983,049
G
ARNT
aryl hydrocarbon receptor nuclear translocator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20935161
G
ATG5
autophagy related 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22491424
NCBI chr13:67,482,538...67,619,201
Ensembl chr13:67,482,595...67,617,902
G
ATOH8
atonal bHLH transcription factor 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr14:21,368,197...21,402,650
G
ATP6V1D
ATPase H+ transporting V1 subunit D
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr24:44,578,057...44,598,918
Ensembl chr24:44,578,807...44,598,394
G
BAD
BCL2 associated agonist of cell death
treatment
ISO
RGD
PMID:25447754
RGD:10053709
NCBI chr 1:9,949,717...9,964,433
Ensembl chr 1:9,949,762...9,964,432
G
BAX
BCL2 associated X, apoptosis regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17906064
NCBI chr 6:42,186,028...42,193,105
G
BDH1
3-hydroxybutyrate dehydrogenase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr15:89,678,844...89,741,848
Ensembl chr15:89,707,046...89,742,434
G
BDKRB2
bradykinin receptor B2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30685357
NCBI chr24:74,084,907...74,125,604
Ensembl chr24:74,118,210...74,122,909
G
BLVRB
biliverdin reductase B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 6:34,902,632...34,925,105
Ensembl chr 6:34,902,598...34,925,100
G
BMAL1
basic helix-loop-helix ARNT like 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:36602574
NCBI chr 1:51,430,670...51,540,344
Ensembl chr 1:51,431,180...51,462,674
G
BPNT1
3'(2'), 5'-bisphosphate nucleotidase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr25:9,489,479...9,518,936
Ensembl chr25:9,490,763...9,519,721
G
BRD4
bromodomain containing 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 6:13,836,332...13,883,459
Ensembl chr 6:13,836,324...13,873,877
G
BTD
biotinidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15469856
NCBI chr15:60,433,035...60,470,600
Ensembl chr15:60,459,913...60,470,615
G
C3
complement C3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr 6:6,250,422...6,289,264
G
CA3
carbonic anhydrase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513 PMID:25231249
NCBI chr 8:80,805,296...80,816,127
Ensembl chr 8:80,805,134...80,816,190
G
CABP1
calcium binding protein 1
ISO
protein:increased expression:liver
RGD
PMID:21138988
RGD:7241599
NCBI chr11:115,934,747...116,021,645
G
CADPS2
calcium dependent secretion activator 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr21:91,117,749...91,669,284
G
CANX
calnexin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr23:81,422,701...81,454,683
Ensembl chr23:81,422,693...81,482,332
G
CAP1
cyclase associated actin cytoskeleton regulatory protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr20:92,833,112...92,865,258
Ensembl chr20:92,829,735...92,864,697
G
CASP8
caspase 8
treatment
ISO
RGD
PMID:25447754
RGD:10053709
NCBI chr10:86,888,654...86,944,159
Ensembl chr10:86,916,527...86,943,829
G
CAST
calpastatin
ISO
RGD
PMID:16871587
RGD:5683869
NCBI chr 4:90,496,867...90,607,019
Ensembl chr 4:90,497,754...90,605,481
G
CAT
catalase
ISO
protein:decreased expression:liver CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:20623750 PMID:21138988 PMID:25231249
RGD:7241599
NCBI chr 1:30,792,533...30,828,920
Ensembl chr 1:30,792,399...30,829,592
G
CCDC80
coiled-coil domain containing 80
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
G
CCL2
C-C motif chemokine ligand 2
treatment
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:20623750 PMID:21813474 PMID:30663942
RGD:14995458 RGD:14995466
NCBI chr16:27,763,354...27,765,437
Ensembl chr16:27,763,555...27,765,416
G
CCR2
C-C motif chemokine receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chr22:7,795,192...7,801,242
Ensembl chr22:7,798,646...7,799,728
G
CCR5
C-C motif chemokine receptor 5
susceptibility
ISO
acetaminophen
RGD
PMID:24770590
RGD:14401733
NCBI chr22:7,803,794...7,818,112
G
CCT3
chaperonin containing TCP1 subunit 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr20:7,518,729...7,545,296
Ensembl chr20:7,518,846...7,545,677
G
CCT5
chaperonin containing TCP1 subunit 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 4:9,787,093...9,802,892
Ensembl chr 4:9,787,101...9,805,852
G
CDC25B
cell division cycle 25B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 2:34,482,709...34,493,737
Ensembl chr 2:34,483,771...34,494,071
G
CDS1
CDP-diacylglycerol synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 7:32,947,644...33,014,807
Ensembl chr 7:32,948,053...33,014,944
G
CELA1
chymotrypsin like elastase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr11:47,526,354...47,545,390
Ensembl chr11:47,526,365...47,544,726
G
CFAP20
cilia and flagella associated protein 20
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 5:44,047,860...44,063,605
Ensembl chr 5:44,047,464...44,063,738
G
CFH
complement factor H
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr25:32,557,697...32,744,763
G
CHRM3
cholinergic receptor muscarinic 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20197374
NCBI chr25:76,772,212...77,009,433
Ensembl chr25:77,001,477...77,003,249
G
CKB
creatine kinase B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr24:81,462,164...81,463,873
G
CLU
clusterin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chr 8:25,704,441...25,721,789
Ensembl chr 8:25,703,257...25,721,789
G
COL14A1
collagen type XIV alpha 1 chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 8:114,701,662...114,946,216
Ensembl chr 8:114,701,664...114,887,483
G
COL3A1
collagen type III alpha 1 chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16679477
NCBI chr10:74,455,133...74,493,392
G
COMT
catechol-O-methyltransferase
ISO
protein:decreased expression:liver
RGD
PMID:21138988
RGD:7241599
NCBI chr19:5,775,829...5,803,260
Ensembl chr19:5,773,225...5,785,422
G
COQ9
coenzyme Q9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 5:43,378,467...43,393,037
Ensembl chr 5:43,378,539...43,392,384
G
CPB2
carboxypeptidase B2
ISO
mRNA,protein:increased expression,increased activity:liver,plasma
RGD
PMID:19386599
RGD:7243112
NCBI chr 3:24,108,854...24,161,669
Ensembl chr 3:24,109,416...24,161,408
G
CPS1
carbamoyl-phosphate synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr10:96,267,890...96,392,393
Ensembl chr10:96,267,889...96,392,206
G
CPT1A
carnitine palmitoyltransferase 1A
ISO
mRNA:decreased expression:liver (rat)
RGD
PMID:28959666
RGD:401794432
NCBI chr 1:5,704,275...5,784,077
Ensembl chr 1:5,730,853...5,784,337
G
CRP
C-reactive protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr20:4,232,262...4,235,826
Ensembl chr20:4,232,913...4,235,377
G
CSF3
colony stimulating factor 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20005281
NCBI chr16:66,162,814...66,166,192
Ensembl chr16:66,163,681...66,165,172
G
CTNNB1
catenin beta 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:19679878
NCBI chr22:2,679,488...2,725,034
Ensembl chr22:2,684,022...2,723,949
G
CTSE
cathepsin E
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr25:23,318,421...23,333,885
Ensembl chr25:23,319,248...23,332,980
G
CXCL1
C-X-C motif chemokine ligand 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16118408
NCBI chr 7:22,327,041...22,329,405
Ensembl chr 7:22,569,355...22,569,900 Ensembl chr 7:22,569,355...22,569,900
G
CXCL10
C-X-C motif chemokine ligand 10
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:11739529
NCBI chr 7:24,526,657...24,529,193
Ensembl chr 7:24,526,680...24,529,130
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33814510
NCBI chr26:8,753,236...8,759,378
Ensembl chr26:8,753,327...8,759,384
G
CYP1A2
cytochrome P450 family 1 subfamily A member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28762043
NCBI chr26:8,727,996...8,733,254
G
CYP1B1
cytochrome P450 family 1 subfamily B member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33814510
NCBI chr14:69,318,713...69,327,277
Ensembl chr14:69,319,495...69,324,157
G
CYP27B1
cytochrome P450 family 27 subfamily B member 1
ISO
mRNA, protein:decreased expression:kidney (mouse)
RGD
PMID:26476181
RGD:25671412
NCBI chr11:53,675,704...53,681,372
Ensembl chr11:53,675,226...53,680,443
G
CYP2B6
cytochrome P450 family 2 subfamily B member 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28762043 PMID:33814510
NCBI chr 6:35,392,699...35,418,171
Ensembl chr 6:35,393,342...35,418,106
G
CYP2C19
cytochrome P450 family 2 subfamily C member 19
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12963435 PMID:28762043
NCBI chr 9:87,981,300...88,025,007
G
CYP2C9
cytochrome P450 family 2 subfamily C member 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:14971821 PMID:21741958 PMID:25226513 PMID:28762043 PMID:33814510
NCBI chr 9:88,082,124...88,125,390
G
CYP2D6
cytochrome P450 family 2 subfamily D member 6
ISO
DNA:hypermethylation:promoter
RGD
PMID:27490558
RGD:14700879
NCBI chr19:24,667,207...24,672,580
Ensembl chr19:24,667,282...24,671,513
G
CYP2E1
cytochrome P450 family 2 subfamily E member 1
treatment
ISO
associated with Endotoxemia DNA:hypermethylation:promoter CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:12668988 PMID:16770646 PMID:21741958 PMID:25681370 PMID:27324775 PMID:27490558 PMID:27960551 PMID:28762043 PMID:29404441 More...
RGD:14700872 RGD:14700873 RGD:14700878 RGD:14700879 RGD:14700901
NCBI chr26:53,390,054...53,403,309
Ensembl chr26:53,390,089...53,404,211
G
CYP8B1
cytochrome P450 family 8 subfamily B member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25448281
NCBI chr22:4,323,840...4,326,459
Ensembl chr22:4,324,396...4,325,901
G
DBT
dihydrolipoamide branched chain transacylase E2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr20:33,088,452...33,157,693
Ensembl chr20:33,088,496...33,140,403
G
DDB1
damage specific DNA binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 1:12,508,712...12,543,127
Ensembl chr 1:12,508,443...12,544,913
G
DGAT2
diacylglycerol O-acyltransferase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17984051
NCBI chr 1:66,985,413...67,018,058
Ensembl chr 1:66,985,466...67,021,182
G
DHFR
dihydrofolate reductase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19648163
NCBI chr 4:74,787,292...74,811,196
Ensembl chr 4:74,787,629...74,810,960
G
DHRS7
dehydrogenase/reductase 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr24:37,368,792...37,389,433
Ensembl chr24:37,368,982...37,389,403
G
DLAT
dihydrolipoamide S-acetyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 1:103,379,165...103,419,585
Ensembl chr 1:103,380,426...103,420,386
G
DNAJB9
DnaJ heat shock protein family (Hsp40) member B9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr21:77,477,177...77,482,190
Ensembl chr21:77,479,112...77,482,571
G
DNAJC12
DnaJ heat shock protein family (Hsp40) member C12
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr 9:63,545,032...63,588,391
Ensembl chr 9:63,545,045...63,588,401
G
DSC2
desmocollin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr18:49,596,870...49,637,587
Ensembl chr18:49,599,940...49,639,526
G
E2F1
E2F transcription factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30515189
NCBI chr 2:37,968,541...37,980,461
Ensembl chr 2:37,968,556...37,980,326
G
ECHDC1
ethylmalonyl-CoA decarboxylase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr13:46,386,543...46,440,730
Ensembl chr13:46,398,058...46,439,533
G
ECHS1
enoyl-CoA hydratase, short chain 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr26:53,212,299...53,222,805
G
EDEM1
ER degradation enhancing alpha-mannosidase like protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr22:41,253,861...41,286,185
Ensembl chr22:41,253,989...41,282,140
G
EIF2AK1
eukaryotic translation initiation factor 2 alpha kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25411909
NCBI chr28:15,225,768...15,269,692
Ensembl chr28:15,233,909...15,269,594
G
EIF4EBP2
eukaryotic translation initiation factor 4E binding protein 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 9:60,867,810...60,894,899
Ensembl chr 9:60,874,602...60,894,919
G
ENDOG
endonuclease G
ISO
protein:decreased expression:mitochondrion:
RGD
PMID:22509279
RGD:9685364
NCBI chr12:9,322,828...9,326,833
Ensembl chr12:9,322,892...9,326,549
G
ENG
endoglin
ISO
protein:increased expression:liver (rat)
RGD
PMID:21146604
RGD:7257529
NCBI chr12:10,274,705...10,315,715
Ensembl chr12:10,275,064...10,315,040
G
ENO1
enolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942 PMID:25231249
NCBI chr20:122,884,846...122,902,669
Ensembl chr20:122,884,727...122,903,372
G
ENPP2
ectonucleotide pyrophosphatase/phosphodiesterase 2
ISO
protein:increased activity:serum:
RGD
PMID:17850827
RGD:9685426
NCBI chr 8:114,113,780...114,232,656
Ensembl chr 8:114,113,778...114,195,956
G
EPHX1
epoxide hydrolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr25:3,924,396...3,960,264
Ensembl chr25:3,924,606...3,945,535
G
ERLEC1
endoplasmic reticulum lectin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr14:53,150,627...53,188,821
Ensembl chr14:53,154,556...53,188,538
G
ERN1
endoplasmic reticulum to nucleus signaling 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30538632
NCBI chr16:57,145,080...57,233,757
Ensembl chr16:57,145,191...57,236,230
G
F13A1
coagulation factor XIII A chain
ISO
RGD
PMID:22019897
RGD:11041813
NCBI chr17:65,885,498...66,040,026
Ensembl chr17:65,885,658...66,040,040
G
F2RL3
F2R like thrombin or trypsin receptor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20974703
NCBI chr 6:15,397,552...15,400,708
G
F3
coagulation factor III, tissue factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22407844
NCBI chr20:38,726,690...38,738,457
Ensembl chr20:38,726,798...38,739,408
G
FADD
Fas associated via death domain
treatment
ISO
RGD
PMID:25447754 PMID:26062544
RGD:10053709 RGD:11341803
NCBI chr 1:4,358,314...4,361,863
G
FADS1
fatty acid desaturase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 1:12,037,173...12,051,907
Ensembl chr 1:12,037,513...12,055,159
G
FADS2
fatty acid desaturase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 1:11,934,352...11,978,355
Ensembl chr 1:11,934,270...11,974,030
G
FASN
fatty acid synthase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr16:73,988,410...74,008,374
Ensembl chr16:73,982,899...74,006,551
G
FCMR
Fc mu receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr25:22,435,252...22,453,582
Ensembl chr25:22,435,339...22,447,732
G
FGA
fibrinogen alpha chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20974703
NCBI chr 7:101,127,554...101,134,881
Ensembl chr 7:101,125,791...101,134,405
G
FGF21
fibroblast growth factor 21
severity
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:29883717
RGD:15045603
NCBI chr 6:42,006,125...42,008,749
Ensembl chr 6:42,006,064...42,008,736
G
FLT1
fms related receptor tyrosine kinase 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21135413
NCBI chr 3:7,412,506...7,608,122
Ensembl chr 3:7,412,172...7,607,967
G
FMO3
flavin containing dimethylaniline monoxygenase 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:24973094
NCBI chr25:57,971,737...57,995,850
Ensembl chr25:57,969,234...57,995,613
G
FTL
ferritin light chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 6:42,196,682...42,198,575
Ensembl chr 6:42,196,538...42,199,614
G
G6PC1
glucose-6-phosphatase catalytic subunit 1
ISO
mRNA:decreased expression:liver (mouse)
RGD
PMID:28189721
RGD:14695531
NCBI chr16:63,380,921...63,392,122
Ensembl chr16:63,381,382...63,391,540
G
G6PD
glucose-6-phosphate dehydrogenase
treatment
ISO
RGD
PMID:21864513
RGD:10449168
NCBI chr X:128,768,028...128,788,366
Ensembl chr X:128,770,268...128,786,961
G
GADD45A
growth arrest and DNA damage inducible alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chr20:65,422,668...65,425,845
Ensembl chr20:65,422,451...65,425,840
G
GANAB
glucosidase II alpha subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 1:11,257,867...11,279,534
Ensembl chr 1:11,257,935...11,281,111
G
GC
GC vitamin D binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr 7:20,254,604...20,298,384
Ensembl chr 7:20,253,879...20,298,265
G
GCLC
glutamate-cysteine ligase catalytic subunit
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:17573345 PMID:19481141
RGD:10402383
NCBI chr17:19,012,994...19,060,617
Ensembl chr17:19,013,026...19,060,659
G
GCLM
glutamate-cysteine ligase modifier subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr20:39,339,948...39,359,980
Ensembl chr20:39,339,908...39,359,430
G
GDA
guanine deaminase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr12:83,195,746...83,305,181
Ensembl chr12:83,195,994...83,306,792
G
GDI1
GDP dissociation inhibitor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
G
GFER
growth factor, augmenter of liver regeneration
treatment
ISO
RGD
PMID:15968720 PMID:22033404
RGD:9685722 RGD:9685727
NCBI chr 5:1,880,025...1,886,829
Ensembl chr 5:1,879,968...1,883,696
G
GGH
gamma-glutamyl hydrolase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21219404
NCBI chr 8:58,908,524...58,932,885
Ensembl chr 8:58,908,417...58,932,685
G
GLUD1
glutamate dehydrogenase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33483742
NCBI chr 9:44,653,044...44,690,142
Ensembl chr 9:44,653,289...44,688,954
G
GOT1
glutamic-oxaloacetic transaminase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 9:92,463,017...92,489,227
Ensembl chr 9:92,462,782...92,488,310
G
GPD1
glycerol-3-phosphate dehydrogenase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr11:46,329,479...46,339,227
Ensembl chr11:46,331,569...46,337,439
G
GPT
glutamic--pyruvic transaminase
treatment
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression, activity:serum:
RGD CTD
PMID:145039 PMID:19085960 PMID:19481104 PMID:21772750 PMID:27293452 PMID:28487901 More...
RGD:14975162 RGD:14975166 RGD:14975168 RGD:14975249
NCBI chr 8:138,716,802...138,721,421
Ensembl chr 8:138,718,767...138,721,251
G
GPT2
glutamic--pyruvic transaminase 2
ISO
protein:increased expression, activity:serum:
RGD
PMID:19085960
RGD:14975249
NCBI chr 5:32,743,850...32,791,299
Ensembl chr 5:32,744,065...32,791,479
G
GRK4
G protein-coupled receptor kinase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr27:45,691,936...45,765,334
G
GSN
gelsolin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr12:18,253,079...18,317,285
Ensembl chr12:18,253,324...18,285,938
G
GSR
glutathione-disulfide reductase
treatment
ISO
mRNA, protein:increased expression:liver CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:23554813 PMID:24154663 PMID:25226513 PMID:28069987
RGD:10401878 RGD:7257532
NCBI chr 8:28,778,713...28,851,907
G
GSTA4
glutathione S-transferase alpha 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr17:19,575,835...19,591,713
Ensembl chr17:19,575,876...19,591,919
G
GSTM3
glutathione S-transferase mu 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:25743375
NCBI chr20:23,797,794...23,802,910
Ensembl chr20:23,799,177...23,802,921
G
GSTO1
glutathione S-transferase omega 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 9:97,305,094...97,317,892
G
GSTP1
glutathione S-transferase pi 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750 PMID:25226513
NCBI chr 1:6,676,897...6,679,936
G
H2AFX
histone H2AX
treatment
ISO
RGD
PMID:23265463
RGD:8693741
NCBI chr 1:110,466,692...110,468,776
Ensembl chr 1:110,467,775...110,468,206
G
HACL1
2-hydroxyacyl-CoA lyase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr15:60,360,380...60,433,528
Ensembl chr15:60,322,722...60,433,647
G
HADHA
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr14:81,411,620...81,468,415
Ensembl chr14:81,411,648...81,472,257
G
HAMP
hepcidin antimicrobial peptide
ISO
mRNA:increased expression:hepatocyte
RGD
PMID:24373749
RGD:11041724
NCBI chr 6:30,214,820...30,218,100
Ensembl chr 6:30,215,563...30,217,996
G
HAO2
hydroxyacid oxidase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr20:14,376,096...14,408,753
Ensembl chr20:14,374,543...14,407,992
G
HAVCR1
hepatitis A virus cellular receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chr23:59,422,769...59,454,183
Ensembl chr23:59,423,334...59,453,531
G
HMGB1
high mobility group box 1
treatment
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:19783637 PMID:29091898
RGD:15090820
NCBI chr 3:9,353,333...9,357,765
G
HMOX1
heme oxygenase 1
treatment
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
RGD CTD
PMID:18227147 PMID:22688006 PMID:22886620 PMID:29091898
RGD:10762620 RGD:15090820
NCBI chr19:18,144,466...18,157,944
Ensembl chr19:18,144,545...18,157,971
G
HPD
4-hydroxyphenylpyruvate dioxygenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942 PMID:22872058
NCBI chr11:117,203,844...117,246,249
Ensembl chr11:117,203,307...117,224,038
G
HPRT1
hypoxanthine phosphoribosyltransferase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr X:109,629,674...109,671,409
G
HPX
hemopexin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr 1:58,385,860...58,396,269
Ensembl chr 1:58,386,190...58,396,298
G
HRH2
histamine receptor H2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22926047
NCBI chr23:77,808,108...77,858,936
Ensembl chr23:77,807,998...77,841,467
G
HSPA5
heat shock protein family A (Hsp70) member 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr12:12,920,705...12,925,888
Ensembl chr12:12,920,710...12,927,431
G
HSPA8
heat shock protein family A (Hsp70) member 8
ISO
protein:altered localization:liver (rat)
RGD
PMID:12376827
RGD:10059389
NCBI chr 1:114,447,348...114,452,693
Ensembl chr 1:114,446,544...114,451,562
G
ICAM1
intercellular adhesion molecule 1
treatment
ISO
RGD
PMID:29091898
RGD:15090820
NCBI chr 6:9,320,991...9,338,125
Ensembl chr 6:9,322,550...9,338,263
G
IDO2
indoleamine 2,3-dioxygenase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32289347
NCBI chr 8:37,951,810...38,027,689
Ensembl chr 8:37,959,078...38,027,632
G
IFNA2
interferon alpha 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:1670585
NCBI chr12:58,468,018...58,469,825
G
IFNG
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12153990 PMID:21245496 PMID:30013034
RGD:14975100
NCBI chr11:63,785,493...63,791,071
Ensembl chr11:63,786,041...63,790,473
G
IGF1
insulin like growth factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23639586 PMID:25226513
NCBI chr11:97,624,498...97,708,730
Ensembl chr11:97,631,189...97,707,308
G
IL11
interleukin 11
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:11421492
NCBI chr 6:47,967,245...47,972,557
Ensembl chr 6:47,967,680...47,971,316
G
IL12B
interleukin 12B
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:36520315
NCBI chr23:61,714,293...61,731,835
G
IL17A
interleukin 17A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19633216 PMID:24949944
NCBI chr17:20,314,082...20,319,917
Ensembl chr17:20,315,773...20,318,785
G
IL18
interleukin 18
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19164858
NCBI chr 1:103,485,868...103,511,632
Ensembl chr 1:103,482,083...103,510,150
G
IL1A
interleukin 1 alpha
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:8218930
NCBI chr14:15,789,710...15,801,938
Ensembl chr14:15,789,013...15,796,611
G
IL1B
interleukin 1 beta
treatment
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
RGD CTD
PMID:19164858 PMID:23102243 PMID:28138970 PMID:29091898 PMID:29278859 PMID:31077717 PMID:31342809 More...
RGD:13793380 RGD:14975281 RGD:15036799 RGD:15090820 RGD:7204421
NCBI chr14:15,844,628...15,852,652
Ensembl chr14:15,844,672...15,850,729
G
IL1R2
interleukin 1 receptor type 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17984051
NCBI chr14:5,672,434...5,708,270
Ensembl chr14:5,673,163...5,708,372
G
IL22
interleukin 22
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15122762 PMID:16212920 PMID:23375450
NCBI chr11:63,881,743...63,887,695
Ensembl chr11:63,882,093...63,886,761
G
IL4
interleukin 4
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:21094227 PMID:21735453 PMID:22107450
NCBI chr23:35,492,158...35,501,349
Ensembl chr23:35,492,939...35,501,258
G
IL6
interleukin 6
treatment
ISO
CTD Direct Evidence: therapeutic
RGD CTD
PMID:7532385 PMID:15763341 PMID:29091898
RGD:15090820
NCBI chr21:35,577,513...35,582,385
Ensembl chr21:35,577,939...35,582,237
G
IMMT
inner membrane mitochondrial protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr14:20,949,586...21,013,535
Ensembl chr14:20,971,622...21,013,197
G
IRAK1
interleukin 1 receptor associated kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr X:128,433,462...128,443,126
Ensembl chr X:128,433,465...128,443,043
G
ITPR1
inositol 1,4,5-trisphosphate receptor type 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr22:40,574,569...40,925,857
Ensembl chr22:40,574,374...40,926,842
G
JUND
JunD proto-oncogene, AP-1 transcription factor subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30515189
NCBI chr 6:16,754,553...16,756,458
Ensembl chr 6:16,755,247...16,756,290
G
KEAP1
kelch like ECH associated protein 1
ISO
RGD
PMID:18417483
RGD:6893370
NCBI chr 6:9,515,789...9,526,699
Ensembl chr 6:9,515,416...9,522,797
G
KITLG
KIT ligand
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:12594235
NCBI chr11:83,856,149...83,943,095
Ensembl chr11:83,856,157...83,943,083
G
KNG1
kininogen 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20362651 PMID:30685357
NCBI chr15:81,002,287...81,027,893
G
KRT18
keratin 18
ISO
mRNA, protein:increased expression:liver (mouse) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:17340120 PMID:19783637 PMID:33483742
RGD:18337498
NCBI chr11:49,073,733...49,081,706
G
KRT8
keratin 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr11:49,027,879...49,051,753
G
LAP3
leucine aminopeptidase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr27:32,616,277...32,647,839
Ensembl chr27:32,616,273...32,647,706
G
LBP
lipopolysaccharide binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 2:25,375,364...25,407,181
Ensembl chr 2:25,374,755...25,406,839
G
LCAT
lecithin-cholesterol acyltransferase
ISO
mRNA:decreased expression:liver (rat)
RGD
PMID:28959666
RGD:401794432
NCBI chr 5:59,495,936...59,500,530
Ensembl chr 5:59,497,115...59,500,448
G
LCN2
lipocalin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20362651 PMID:20623750
NCBI chr12:9,976,278...9,981,087
Ensembl chr12:9,976,614...9,980,870
G
LDLR
low density lipoprotein receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36108984
NCBI chr 6:10,062,204...10,091,780
Ensembl chr 6:10,062,790...10,091,377
G
LGALS3
galectin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22461450
NCBI chr24:32,311,343...32,328,335
Ensembl chr24:32,311,271...32,328,339
G
LIPC
lipase C, hepatic type
ISO
mRNA:decreased expression:liver (rat)
RGD
PMID:28959666
RGD:401794432
NCBI chr26:24,946,843...25,109,338
Ensembl chr26:24,946,673...25,087,921
G
LOC103223058
glutathione hydrolase light chain 2
ISO
RGD
PMID:10934156
RGD:14701049
NCBI chr19:7,353,922...7,406,392
G
LOC103223491
peroxisome proliferator-activated receptor alpha
ISO
LPS-induced acute liver damage
RGD
PMID:21262334
RGD:5509941
NCBI chr19:28,614,892...28,709,272
Ensembl chr19:28,615,413...28,708,763
G
LOC103224275
glutathione S-transferase Mu 1
no_association
ISO
protein:increased expression:liver CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:17465707 PMID:18666253 PMID:21138988 PMID:24465778 PMID:24903797 PMID:25501156 PMID:29523098 More...
RGD:14700937 RGD:14700941 RGD:14700959 RGD:14700970 RGD:7241599
NCBI chr20:23,854,969...23,861,634
G
LOC103230356
uncharacterized LOC103230356
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29515023
NCBI chr25:29,230,358...29,380,617
Ensembl chr25:29,233,558...29,379,922
G
LOC103231165
isocitrate dehydrogenase (NADP(+)) 2
severity
ISO
RGD
PMID:31121248
RGD:14985250
NCBI chr29:8,633,429...8,650,744
Ensembl chr29:8,633,715...8,650,657
G
LOC103233689
thromboxane A2 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22206755
NCBI chr 6:3,354,358...3,365,779
Ensembl chr 6:3,355,314...3,359,761
G
LOC103238261
tubulin alpha-1A chain
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr11:45,419,046...45,423,574
Ensembl chr11:45,418,748...45,423,685
G
LOC103242911
nucleoside diphosphate kinase B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr16:42,176,690...42,182,041
Ensembl chr16:42,176,524...42,182,019
G
LOC103246766
cytochrome P450 3A8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28762043
NCBI chr28:13,297,566...13,330,023
G
LOC103247947
olfactory receptor 51E2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 1:62,172,573...62,180,085
Ensembl chr 1:62,177,553...62,178,515
G
LPL
lipoprotein lipase
treatment
ISO
RGD
PMID:27071702
RGD:13794380
NCBI chr 8:18,009,049...18,038,315
Ensembl chr 8:18,009,093...18,038,598
G
LRAT
lecithin retinol acyltransferase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 7:101,297,114...101,304,675
Ensembl chr 7:101,297,691...101,302,520
G
LTB4R
leukotriene B4 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28487374
NCBI chr24:1,294,453...1,301,113
Ensembl chr24:1,298,729...1,299,790
G
LTF
lactotransferrin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16141546
NCBI chr22:7,867,332...7,896,403
Ensembl chr22:7,867,286...7,894,521
G
MAP1LC3B
microtubule associated protein 1 light chain 3 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 5:72,762,428...72,774,204
Ensembl chr 5:72,763,050...72,772,770
G
MAP3K5
mitogen-activated protein kinase kinase kinase 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18700144
NCBI chr13:36,614,489...36,858,524
Ensembl chr13:36,615,633...36,858,601
G
MAT1A
methionine adenosyltransferase 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 9:51,540,162...51,558,076
Ensembl chr 9:51,540,162...51,558,576
G
MCCC1
methylcrotonyl-CoA carboxylase subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr15:6,318,788...6,400,539
Ensembl chr15:6,318,791...6,401,849
G
MDH1
malate dehydrogenase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr14:43,406,502...43,425,525
Ensembl chr14:43,406,499...43,425,095
G
ME1
malic enzyme 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr13:7,889,211...8,112,793
Ensembl chr13:7,887,984...8,112,533
G
MED1
mediator complex subunit 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16109766
NCBI chr16:66,719,393...66,764,902
Ensembl chr16:66,719,423...66,762,896
G
MHC-DQA1
major histocompatibility complex, class II, DQ alpha 1
susceptibility
ISO
associated with tuberculosis;DNA:polymorphism: :HLA-DQA1*0102(human)
RGD
PMID:12359646 PMID:20639878
RGD:14398844 RGD:14401573
NCBI chr17:39,422,445...39,428,777
Ensembl chr17:39,420,134...39,428,871
G
MMP2
matrix metallopeptidase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15763341
NCBI chr 5:41,264,382...41,291,657
Ensembl chr 5:41,264,354...41,291,004
G
MMP9
matrix metallopeptidase 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22507835
NCBI chr 2:17,867,267...17,874,757
Ensembl chr 2:17,867,177...17,874,712
G
MST1
macrophage stimulating 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr22:11,078,662...11,083,885
Ensembl chr22:11,074,114...11,083,368
G
MST1R
macrophage stimulating 1 receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22575169
NCBI chr22:11,293,637...11,310,239
Ensembl chr22:11,293,263...11,309,980
G
MTHFR
methylenetetrahydrofolate reductase
treatment
ISO
associated with precursor lymphoblastic lymphoma/leukemia; DNA:SNP: :677C>T(human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:18551038 PMID:19648163 PMID:30545275
RGD:14696733
NCBI chr20:119,987,667...120,003,611
Ensembl chr20:119,990,133...120,002,950
G
MTPN
myotrophin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr21:104,605,924...104,657,664
Ensembl chr21:104,605,592...104,657,866
G
MYD88
MYD88 innate immune signal transduction adaptor
ameliorates
ISO
RGD
PMID:17615358
RGD:150521532
NCBI chr15:1,276,804...1,281,811
Ensembl chr15:1,276,798...1,281,166
G
NAT2
N-acetyltransferase 2
treatment
ISO
CTD Direct Evidence: marker/mechanism associated with Tuberculosis;DNA:haplotype: :
CTD RGD
PMID:11915035 PMID:16799928 PMID:17950035 PMID:18023090 PMID:25693865
RGD:8552665
NCBI chr 8:16,451,144...16,494,961
Ensembl chr 8:16,493,749...16,494,621
G
NDUFS3
NADH:ubiquinone oxidoreductase core subunit S3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 1:17,735,040...17,740,508
Ensembl chr 1:17,733,645...17,745,677
G
NFATC4
nuclear factor of activated T cells 4
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:34192554
NCBI chr24:1,352,173...1,362,150
Ensembl chr24:1,352,291...1,362,680
G
NFE2L2
NFE2 like bZIP transcription factor 2
treatment
ISO
CTD Direct Evidence: therapeutic induced by methotrexate (CHEBI:44185), treated by ferulic acid (CHEBI:17620)
CTD RGD
PMID:18417483 PMID:22491424 PMID:22627062 PMID:24813929 PMID:26958860 PMID:29091898 PMID:30215777 PMID:31889292 PMID:31927046 PMID:31972209 PMID:32066295 More...
RGD:15090820 RGD:21201280 RGD:21201283 RGD:21201305 RGD:21201308 RGD:6893370
NCBI chr10:62,789,647...62,825,651
Ensembl chr10:62,790,124...62,825,339
G
NFKB1
nuclear factor kappa B subunit 1
susceptibility treatment
ISO
associated with tuberculosis ;DNA:SNPs,haplotypes: 3'utr,5'utr: (rs78872571,rs4647992) (human)
RGD
PMID:29091898 PMID:31490979
RGD:15090820 RGD:40902984
NCBI chr 7:50,589,494...50,711,472
Ensembl chr 7:50,589,856...50,711,498
G
NFXL1
nuclear transcription factor, X-box binding like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr27:2,333,158...2,401,008
Ensembl chr27:2,333,809...2,400,084
G
NOTCH1
notch receptor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:30394310
NCBI chr12:1,656,815...1,707,566
Ensembl chr12:1,656,918...1,709,585
G
NOX4
NADPH oxidase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 1:80,470,418...80,642,513
Ensembl chr 1:80,470,826...80,642,722
G
NQO1
NAD(P)H quinone dehydrogenase 1
treatment
ISO
RGD
PMID:28472605 PMID:28522909 PMID:29091898
RGD:13439737 RGD:13439739 RGD:15090820
NCBI chr 5:57,676,547...57,695,434
Ensembl chr 5:57,675,981...57,716,599
G
NR0B2
nuclear receptor subfamily 0 group B member 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:29943110
NCBI chr20:105,850,328...105,853,076
Ensembl chr20:105,850,598...105,853,060
G
NR1D1
nuclear receptor subfamily 1 group D member 1
treatment
ISO
RGD
PMID:24497272
RGD:10448995
NCBI chr16:66,078,990...66,086,927
Ensembl chr16:66,079,089...66,090,685
G
NR1H3
nuclear receptor subfamily 1 group H member 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:17256725
NCBI chr 1:18,041,495...18,061,196
Ensembl chr 1:18,041,830...18,051,501
G
NR1H4
nuclear receptor subfamily 1 group H member 4
severity treatment
ISO
CTD Direct Evidence: marker/mechanism protein:decreased expression:liver (rat) mRNA:decreased expression:liver (rat)
CTD RGD
PMID:12875239 PMID:20573685 PMID:22711662 PMID:28827769 PMID:29091898 PMID:30068870 More...
RGD:14701035 RGD:14701036 RGD:15042870 RGD:15045609 RGD:15090820
NCBI chr11:95,792,428...95,877,989
Ensembl chr11:95,792,996...95,878,293
G
NR1I2
nuclear receptor subfamily 1 group I member 2
susceptibility
ISO
associated with tuberculosis ;DNA:SNP,haplotypes:promoter: (rs3814055) (human) CTD Direct Evidence: marker/mechanism|therapeutic
RGD CTD
PMID:19797606 PMID:28058446 PMID:31490979
RGD:40902984
NCBI chr22:61,005,404...61,043,016
Ensembl chr22:61,006,667...61,040,832
G
NR1I3
nuclear receptor subfamily 1 group I member 3
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:14742670 PMID:25656644 PMID:28058446
NCBI chr20:2,724,843...2,752,999
Ensembl chr20:2,744,908...2,756,658
G
NR2F2
nuclear receptor subfamily 2 group F member 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr29:14,889,526...14,901,848
Ensembl chr29:14,891,737...14,903,813
G
NREP
neuronal regeneration related protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr23:15,065,565...15,314,999
Ensembl chr23:15,064,445...15,093,992
G
NTN1
netrin 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:35292334
NCBI chr16:8,359,682...8,603,231
Ensembl chr16:8,379,129...8,603,223
G
NUS1
NUS1 dehydrodolichyl diphosphate synthase subunit
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:33812996
NCBI chr13:56,115,581...56,147,918
Ensembl chr13:56,113,428...56,147,982
G
OCIAD1
OCIA domain containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr27:1,394,512...1,424,286
Ensembl chr27:1,391,852...1,424,270
G
OGDH
oxoglutarate dehydrogenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr21:13,975,825...14,070,216
Ensembl chr21:13,973,845...14,070,731
G
P4HB
prolyl 4-hydroxylase subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr16:73,718,743...73,733,488
Ensembl chr16:73,718,656...73,733,892
G
PAH
phenylalanine hydroxylase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr11:98,065,869...98,140,011
Ensembl chr11:98,063,199...98,139,285
G
PAN2
poly(A) specific ribonuclease subunit PAN2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr11:52,273,867...52,290,514
Ensembl chr11:52,274,540...52,289,410
G
PANX1
pannexin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29246445
NCBI chr 1:85,356,507...85,413,146
Ensembl chr 1:85,356,610...85,409,275
G
PARK7
Parkinsonism associated deglycase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr20:123,776,084...123,808,031
Ensembl chr20:123,776,297...123,798,434
G
PC
pyruvate carboxylase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 1:7,310,738...7,418,357
Ensembl chr 1:7,357,246...7,417,998
G
PCOLCE
procollagen C-endopeptidase enhancer
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr28:12,604,552...12,610,814
Ensembl chr28:12,604,526...12,610,814
G
PCYT1A
phosphate cytidylyltransferase 1A, choline
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr15:90,905,691...90,944,485
G
PDK4
pyruvate dehydrogenase kinase 4
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:21182459 PMID:31809757
NCBI chr21:53,445,607...53,458,729
Ensembl chr21:53,445,457...53,460,776
G
PDLIM5
PDZ and LIM domain 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 7:42,702,175...42,912,859
Ensembl chr 7:42,819,454...42,908,137
G
PEX11A
peroxisomal biogenesis factor 11 alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr29:8,220,082...8,229,448
Ensembl chr29:8,221,920...8,229,243
G
PGM1
phosphoglucomutase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr20:69,391,487...69,495,156
Ensembl chr20:69,428,996...69,466,191
G
PLAT
plasminogen activator, tissue type
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22507835
NCBI chr 8:40,164,391...40,196,627
Ensembl chr 8:40,163,891...40,196,555
G
PLG
plasminogen
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22507835
NCBI chr13:88,266,054...88,321,596
Ensembl chr13:88,268,198...88,322,644
G
PLS3
plastin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
G
PNP
purine nucleoside phosphorylase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr29:20,992,892...21,001,400
Ensembl chr29:20,993,280...21,001,606
G
PNRC1
proline rich nuclear receptor coactivator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr13:13,846,691...13,850,785
Ensembl chr13:13,846,864...13,850,141
G
POLG
DNA polymerase gamma, catalytic subunit
susceptibility no_association
ISO
DNA:missense mutation:cds:p.W748S, p.E1143G (2243G>C, 3428A>G) (human) DNA:missense mutations:cds:p.Q1236H, p.E1143G (33708G>T, 3428A>G) (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:18208989 PMID:20138553 PMID:25065347 PMID:30255931
RGD:15039297 RGD:15039302
NCBI chr29:7,864,319...7,881,577
Ensembl chr29:7,863,277...7,882,068
G
POLR2G
RNA polymerase II subunit G
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 1:11,140,897...11,150,879
Ensembl chr 1:11,140,867...11,150,882
G
PON1
paraoxonase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr21:53,713,434...53,739,658
Ensembl chr21:53,714,012...53,739,875
G
PPARA
peroxisome proliferator activated receptor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24385052
G
PPARG
peroxisome proliferator activated receptor gamma
ISO
mRNA, protein:decreased expression:liver
RGD
PMID:26599535
RGD:11554658
NCBI chr22:48,262,743...48,407,415
Ensembl chr22:48,275,600...48,407,418
G
PPTC7
protein phosphatase targeting COQ7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr11:105,774,912...105,823,882
Ensembl chr11:105,778,596...105,823,836
G
PRKAA1
protein kinase AMP-activated catalytic subunit alpha 1
treatment
ISO
RGD
PMID:29091898
RGD:15090820
NCBI chr 4:39,516,307...39,553,627
G
PRKCD
protein kinase C delta
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:30393195
NCBI chr22:14,561,401...14,592,877
Ensembl chr22:14,565,282...14,592,873
G
PRKDC
protein kinase, DNA-activated, catalytic subunit
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21224054
NCBI chr 8:43,915,226...44,119,547
Ensembl chr 8:43,914,636...44,119,541
G
PTF1A
pancreas associated transcription factor 1a
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:21182459
NCBI chr 9:22,944,122...22,965,905
Ensembl chr 9:22,964,164...22,965,565
G
PTGS2
prostaglandin-endoperoxide synthase 2
treatment
ISO
CTD Direct Evidence: therapeutic
RGD CTD
PMID:11743745 PMID:29091898
RGD:15090820
NCBI chr25:42,733,535...42,742,463
Ensembl chr25:42,734,771...42,742,429
G
PUM1
pumilio RNA binding family member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr20:101,773,819...101,910,433
Ensembl chr20:101,773,960...101,910,519
G
PYGL
glycogen phosphorylase L
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:serum (rat)
CTD RGD
PMID:25231249 PMID:25336395
RGD:21079733
NCBI chr24:27,987,676...28,030,919
Ensembl chr24:27,987,649...28,030,869
G
PZP
PZP alpha-2-macroglobulin like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr11:8,963,883...9,023,148
Ensembl chr11:8,963,461...9,014,957
G
RASA1
RAS p21 protein activator 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr 4:81,249,851...81,371,486
Ensembl chr 4:81,249,805...81,370,453
G
RBP1
retinol binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr15:51,011,664...51,033,963
G
RDH13
retinol dehydrogenase 13
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27865848
NCBI chr 6:47,634,909...47,652,829
Ensembl chr 6:47,636,094...47,652,772
G
REEP5
receptor accessory protein 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr23:16,165,233...16,210,082
Ensembl chr23:16,167,557...16,210,050
G
RGN
regucalcin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr X:44,282,825...44,299,027
Ensembl chr X:44,285,601...44,299,258
G
RIPK3
receptor interacting serine/threonine kinase 3
ISO
CTD Direct Evidence: therapeutic protein:increased expression:liver (mouse)
CTD RGD
PMID:26769846 PMID:28205631
RGD:127229945
NCBI chr24:1,318,265...1,322,610
Ensembl chr24:1,318,216...1,322,462
G
S100A11
S100 calcium binding protein A11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr20:11,613,171...11,617,711
G
SCARB1
scavenger receptor class B member 1
ISO
mRNA:increased expression:liver (rat)
RGD
PMID:28959666
RGD:401794432
NCBI chr11:120,134,485...120,223,512
Ensembl chr11:120,134,874...120,216,904
G
SELENBP1
selenium binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chr20:12,321,445...12,330,495
Ensembl chr20:12,321,292...12,330,746
G
SEMA3A
semaphorin 3A
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:33290778
NCBI chr21:64,723,860...64,942,705
Ensembl chr21:64,784,039...64,939,682
G
SEMA4A
semaphorin 4A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33290778
NCBI chr20:7,684,107...7,716,866
Ensembl chr20:7,683,994...7,708,741
G
SENP2
SUMO specific peptidase 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:29535048
NCBI chr15:3,805,916...3,853,529
G
SERPINA1
serpin family A member 1
susceptibility
ISO
protein:decreased expression:plasma DNA:missense mutation:cds:p.E264V(human)
RGD
PMID:11140575 PMID:20170533
RGD:14695048 RGD:1643168
NCBI chr24:72,158,521...72,171,139
Ensembl chr24:72,156,784...72,163,500
G
SERPINA6
serpin family A member 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr24:72,079,084...72,098,549
Ensembl chr24:72,077,274...72,098,154
G
SERPINE1
serpin family E member 1
treatment
ISO
associated with precursor lymphoblastic lymphoma/leukemia;DNA:SNPs: :DNA:SNPs: :677C>T, 1298A>C(human)
RGD
PMID:23183238
RGD:14696750
NCBI chr28:12,047,520...12,060,662
Ensembl chr28:12,047,529...12,060,202
G
SERPING1
serpin family G member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 1:15,617,122...15,634,540
Ensembl chr 1:15,616,674...15,633,855
G
SESN2
sestrin 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:28209544
NCBI chr20:104,521,131...104,544,161
Ensembl chr20:104,521,132...104,544,001
G
SGF29
SAGA complex associated factor 29
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 5:26,399,760...26,439,616
Ensembl chr 5:26,399,677...26,439,530
G
SHC1
SHC adaptor protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249 PMID:32659284
NCBI chr20:8,854,189...8,866,406
Ensembl chr20:8,858,458...8,866,610
G
SLC10A1
solute carrier family 10 member 1
ISO
mRNA:decreased expression:liver (rat)
RGD
PMID:28827769
RGD:15045609
NCBI chr24:47,018,237...47,034,360
Ensembl chr24:47,017,414...47,033,940
G
SLC10A7
solute carrier family 10 member 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr 7:92,798,344...93,052,737
G
SLC13A4
solute carrier family 13 member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr21:104,359,577...104,407,905
Ensembl chr21:104,363,792...104,405,562
G
SLC22A8
solute carrier family 22 member 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 1:10,885,895...10,909,739
Ensembl chr 1:10,886,690...10,910,546
G
SLC25A29
solute carrier family 25 member 29
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr24:78,251,571...78,266,550
Ensembl chr24:78,250,796...78,266,490
G
SLC7A5
solute carrier family 7 member 5
treatment
ISO
RGD
PMID:9200186
RGD:151357001
NCBI chr 5:73,229,953...73,269,801
Ensembl chr 5:73,229,951...73,269,754
G
SLCO1B1
solute carrier organic anion transporter family member 1B1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32259555
NCBI chr11:20,992,353...21,091,761
Ensembl chr11:21,001,655...21,093,278
G
SLPI
secretory leukocyte peptidase inhibitor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17984051
NCBI chr 2:18,579,549...18,581,897
Ensembl chr 2:18,579,515...18,582,076
G
SNX18
sorting nexin 18
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17984051
NCBI chr 4:50,782,842...50,810,220
Ensembl chr 4:50,782,929...50,811,253
G
SOD1
superoxide dismutase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750 PMID:27349771
NCBI chr 2:60,461,219...60,472,999
G
SOD2
superoxide dismutase 2
susceptibility severity treatment
ISO
DNA:SNP:cds:p.Val16Ala(human) associated with acute lymphoblastic leukemia;DNA:SNP: :(rs4880)(human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:19332662 PMID:19647030 PMID:20578157 PMID:25226513 PMID:27019981
RGD:11060605 RGD:26923957 RGD:26923959 RGD:26923961
NCBI chr13:87,284,537...87,297,998
Ensembl chr13:87,280,686...87,297,974
G
SOD3
superoxide dismutase 3
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:11529661
NCBI chr27:25,554,474...25,559,873
Ensembl chr27:25,555,082...25,555,804
G
SORD
sorbitol dehydrogenase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12763371
NCBI chr26:38,129,236...38,173,867
Ensembl chr26:38,126,911...38,155,381
G
SORL1
sortilin related receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr 1:112,877,052...113,062,167
Ensembl chr 1:112,877,151...113,058,050
G
SPP1
secreted phosphoprotein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20623750
NCBI chr 7:36,337,165...36,344,927
Ensembl chr 7:36,338,386...36,344,407
G
SRP72
signal recognition particle 72
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr 7:12,127,817...12,162,992
Ensembl chr 7:12,126,607...12,162,951
G
STAT4
signal transducer and activator of transcription 4
severity
ISO
protein:increased phosphorylation:liver, inflammatory cell (mouse) mRNA:increased expression:liver, macrophage (mouse)
RGD
PMID:23876342 PMID:24731448
RGD:25671417 RGD:25671422
NCBI chr10:76,553,626...76,708,540
Ensembl chr10:76,553,606...76,674,928
G
STING1
stimulator of interferon response cGAMP interactor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:36520315
NCBI chr23:42,153,576...42,160,903
Ensembl chr23:42,153,026...42,160,907
G
SULT1C3
sulfotransferase family 1C member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr14:11,621,851...11,638,719
Ensembl chr14:11,622,043...11,636,652
G
SULT1E1
sulfotransferase family 1E member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 7:18,313,510...18,330,768
Ensembl chr 7:18,313,238...18,330,741
G
SULT2B1
sulfotransferase family 2B member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:27052460
NCBI chr 6:41,809,654...41,852,685
Ensembl chr 6:41,810,049...41,852,681
G
SUOX
sulfite oxidase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr11:51,935,809...51,943,090
Ensembl chr11:51,939,809...51,942,603
G
TAGLN2
transgelin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr20:4,024,948...4,032,361
Ensembl chr20:4,024,775...4,032,526
G
TALDO1
transaldolase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19436114
NCBI chr 1:553,475...569,935
Ensembl chr 1:553,458...573,546
G
TCTN1
tectonic family member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17984051
NCBI chr11:105,855,138...105,898,764
Ensembl chr11:105,855,288...105,891,093
G
TF
transferrin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr15:56,586,311...56,618,304
Ensembl chr15:56,586,104...56,618,149
G
TGFB1
transforming growth factor beta 1
treatment
ISO
RGD
PMID:27516150
RGD:14995464
NCBI chr 6:35,651,583...35,674,387
Ensembl chr 6:35,648,677...35,674,365
G
TGFBR1
transforming growth factor beta receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28560358
NCBI chr12:40,272,507...40,321,740
Ensembl chr12:40,276,916...40,297,372
G
THBS1
thrombospondin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35357534
NCBI chr26:43,410,693...43,427,816
Ensembl chr26:43,410,580...43,427,812
G
THPO
thrombopoietin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:33122006
NCBI chr15:5,040,684...5,048,387
G
TLR4
toll like receptor 4
disease_progression
ISO
RGD
PMID:17504260
RGD:14697733
NCBI chr12:21,873,762...21,885,562
Ensembl chr12:21,871,773...21,885,515
G
TLR5
toll like receptor 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:30508503
NCBI chr25:6,418,895...6,440,433
Ensembl chr25:6,437,638...6,440,211
G
TMED7
transmembrane p24 trafficking protein 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr23:18,864,021...18,875,089
Ensembl chr23:18,866,758...18,874,975
G
TMEM117
transmembrane protein 117
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr11:40,049,469...40,590,373
G
TMEM164
transmembrane protein 164
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr X:97,833,179...98,007,700
Ensembl chr X:97,833,496...98,003,343
G
TMEM38B
transmembrane protein 38B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr12:33,759,311...33,840,357
Ensembl chr12:33,759,157...33,840,009
G
TNF
tumor necrosis factor
treatment severity
ISO
protein:increased expression:serum (rat) CTD Direct Evidence: marker/mechanism|therapeutic
RGD CTD
PMID:7532385 PMID:9309314 PMID:9696492 PMID:10801287 PMID:10801288 PMID:11124822 PMID:14686721 PMID:15830285 PMID:17070847 PMID:17709330 PMID:19638433 PMID:20623750 PMID:21984482 PMID:29091898 PMID:31077717 PMID:31342809 PMID:37866487 More...
RGD:10450531 RGD:14696804 RGD:14975281 RGD:14995429 RGD:14995432 RGD:14995435 RGD:14995437 RGD:14995485 RGD:15036799 RGD:15090820
G
TRPM2
transient receptor potential cation channel subfamily M member 2
ISO
RGD
PMID:24569808
RGD:9999438
NCBI chr 2:88,082,391...88,170,340
Ensembl chr 2:88,087,448...88,170,344
G
TTR
transthyretin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16099942
NCBI chr18:49,124,302...49,131,495
Ensembl chr18:49,124,121...49,131,399
G
TUBB4B
tubulin beta 4B class IVb
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr12:945,643...948,087
Ensembl chr12:945,459...948,065
G
UBA5
ubiquitin like modifier activating enzyme 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26881866
NCBI chr15:57,596,490...57,613,103
Ensembl chr15:57,592,728...57,612,928
G
UNC93B1
unc-93 homolog B1, TLR signaling regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 1:6,537,198...6,549,457
Ensembl chr 1:6,537,273...6,549,450
G
USP5
ubiquitin specific peptidase 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr11:6,885,401...6,899,983
Ensembl chr11:6,885,311...6,898,442
G
VEGFA
vascular endothelial growth factor A
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17784864 PMID:25231249
RGD:15003197
NCBI chr17:28,377,959...28,394,508
G
VIM
vimentin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr 9:17,183,466...17,191,771
Ensembl chr 9:17,183,388...17,191,829
G
VWF
von Willebrand factor
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:liver:
CTD RGD
PMID:7531171 PMID:28527913
RGD:11079232
NCBI chr11:5,994,499...6,176,949
Ensembl chr11:5,994,039...6,162,260
G
WASL
WASP like actin nucleation promoting factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr21:92,480,392...92,546,725
Ensembl chr21:92,482,918...92,546,481
G
XRCC1
X-ray repair cross complementing 1
susceptibility
ISO
DNA:haploinsufficiency: : (mouse)
RGD
PMID:21737425
RGD:15036796
NCBI chr 6:37,062,149...37,095,138
Ensembl chr 6:37,060,439...37,095,094
G
XYLB
xylulokinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25231249
NCBI chr15:1,003,809...1,070,385
Ensembl chr15:1,005,340...1,069,275
G
ZDHHC23
zinc finger DHHC-type palmitoyltransferase 23
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25226513
NCBI chr22:66,905,388...66,917,104
Ensembl chr22:66,901,395...66,915,702
G
ABCC2
ATP binding cassette subfamily C member 2
no_association susceptibility
ISO
DNA:SNPs:multiple: DNA:polymorphisms,haplotype:promoter:g.-1774delG,g.-1549G>A(human)
RGD
PMID:17502832 PMID:22178260
RGD:14700816 RGD:14700817
NCBI chr 9:92,826,423...92,902,389
Ensembl chr 9:92,841,818...92,902,265
G
CYP2E1
cytochrome P450 family 2 subfamily E member 1
ISO
DNA:hypermethylation:promoter
RGD
PMID:23619520
RGD:14700910
NCBI chr26:53,390,054...53,403,309
Ensembl chr26:53,390,089...53,404,211
G
HMGCR
3-hydroxy-3-methylglutaryl-CoA reductase
ISO
RGD
PMID:16140414
RGD:2316848
NCBI chr 4:69,664,784...69,690,343
Ensembl chr 4:69,665,417...69,688,686
G
LPAR1
lysophosphatidic acid receptor 1
ISO
protein:increased expression:liver (mouse)
RGD
PMID:12201952
RGD:10054288
NCBI chr12:28,502,717...28,669,581
Ensembl chr12:28,503,354...28,669,795
G
GPT
glutamic--pyruvic transaminase
treatment
ISO
RGD
PMID:28921207
RGD:14975164
NCBI chr 8:138,716,802...138,721,421
Ensembl chr 8:138,718,767...138,721,251
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all